Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
株式のランク #33690
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
株価
$4.70
最終同期: 2026-08-14
時価総額
$7.09M
変化(1日)
-0.21%
変化(1年)
-70.63%
US
取引 Apimeds Pharmaceuticals US, Inc (APUS)

カテゴリー

Apimeds Pharmaceuticals US, Inc(APUS)の株価履歴
終値の最高値: $4.53 (2026-08-01)

終値の最安値: $18.03 (2025-05-01)
Apimeds Pharmaceuticals US, Inc の株価履歴(2025 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -15.19%
2025 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$505.24 28.63%
US
$846.09 29.41%
NL
$734.04 6.81%
CH
$1.07K -6.40%
KR
$255.38 13.33%
BE